Lanxiang Jiang

876 total citations
19 papers, 750 citations indexed

About

Lanxiang Jiang is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Lanxiang Jiang has authored 19 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Lanxiang Jiang's work include Immune Response and Inflammation (6 papers), NF-κB Signaling Pathways (5 papers) and Biological and pharmacological studies of plants (3 papers). Lanxiang Jiang is often cited by papers focused on Immune Response and Inflammation (6 papers), NF-κB Signaling Pathways (5 papers) and Biological and pharmacological studies of plants (3 papers). Lanxiang Jiang collaborates with scholars based in China. Lanxiang Jiang's co-authors include Xuming Deng, Miaomiao Wei, Meixia Huo, Haihua Feng, Xiao Chu, Lanan Wassy Soromou, Na Chen, Weiting Zhong, Xianxing Xie and Xinxin Ci and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Molecules and Postharvest Biology and Technology.

In The Last Decade

Lanxiang Jiang

18 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanxiang Jiang China 14 322 153 128 121 110 19 750
Yun Hee Jeong South Korea 16 315 1.0× 133 0.9× 78 0.6× 119 1.0× 86 0.8× 41 686
Xianxing Xie China 11 294 0.9× 105 0.7× 171 1.3× 143 1.2× 113 1.0× 11 688
Nur Aziz South Korea 11 330 1.0× 115 0.8× 116 0.9× 104 0.9× 117 1.1× 21 780
Seon‐A Jang South Korea 16 386 1.2× 167 1.1× 73 0.6× 116 1.0× 73 0.7× 52 721
Gefu Chi China 15 443 1.4× 182 1.2× 189 1.5× 139 1.1× 131 1.2× 22 918
Xiaojun Zhang China 18 452 1.4× 109 0.7× 86 0.7× 136 1.1× 79 0.7× 25 773
Hyungwoo Kim South Korea 15 299 0.9× 113 0.7× 76 0.6× 95 0.8× 136 1.2× 64 703
Eun‐Hwa Sohn South Korea 16 411 1.3× 143 0.9× 78 0.6× 110 0.9× 77 0.7× 45 774
Jin Mi Chun South Korea 18 431 1.3× 202 1.3× 74 0.6× 151 1.2× 146 1.3× 70 869
Rashida Ginwala United States 10 272 0.8× 138 0.9× 116 0.9× 72 0.6× 75 0.7× 18 692

Countries citing papers authored by Lanxiang Jiang

Since Specialization
Citations

This map shows the geographic impact of Lanxiang Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanxiang Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanxiang Jiang more than expected).

Fields of papers citing papers by Lanxiang Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanxiang Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanxiang Jiang. The network helps show where Lanxiang Jiang may publish in the future.

Co-authorship network of co-authors of Lanxiang Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lanxiang Jiang. A scholar is included among the top collaborators of Lanxiang Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanxiang Jiang. Lanxiang Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
3.
Jiang, Lanxiang, et al.. (2023). Controlled atmosphere storage of krypton, xenon and oxygen inhibits yellowing and maintains quality of fresh peeled water chestnuts (Eleocharis dulcis). Postharvest Biology and Technology. 210. 112745–112745. 3 indexed citations
4.
Wang, Guixia, Li Liu, Xiaobo Wang, et al.. (2023). Analysis of Physician Compliance with Guideline-Directed Medical Therapy for Patients with Heart Failure with Reduced Ejection Fraction: A Real-World Study. Reviews in Cardiovascular Medicine. 24(9). 257–257.
5.
Xu, Yangchun, Sheng Wang, Lanxiang Jiang, & Xuan Zhang. (2019). Novel MicroRNA Biomarkers, miR-142-5p , miR-550a , miR-1826 , and miR-1201 , Were Identified for Primary Melanoma. Journal of Computational Biology. 27(5). 815–824. 7 indexed citations
6.
Jiang, Lanxiang, et al.. (2019). Aloe-emodin Attenuates Staphylococcus aureus Pathogenicity by Interfering With the Oligomerization of α-Toxin. Frontiers in Cellular and Infection Microbiology. 9. 157–157. 40 indexed citations
7.
Zhang, Mingrui, et al.. (2019). Simultaneous dermatophytosis and keratomycosis caused by Trichophyton interdigitale infection: a case report and literature review. BMC Infectious Diseases. 19(1). 18 indexed citations
8.
Jiang, Lanxiang, Hongen Li, Lei Shi, et al.. (2016). Isorhamnetin Attenuates Staphylococcus aureus-Induced Lung Cell Injury by Inhibiting Alpha-Hemolysin Expression. Journal of Microbiology and Biotechnology. 26(3). 596–602. 32 indexed citations
9.
Chu, Xiao, Lanxiang Jiang, Miaomiao Wei, et al.. (2013). Attenuation of allergic airway inflammation in a murine model of asthma by Licochalcone A. Immunopharmacology and Immunotoxicology. 35(6). 653–661. 28 indexed citations
10.
Zhong, Weiting, Lanxiang Jiang, Jingyuan Wei, et al.. (2013). Protective effect of esculentoside A on lipopolysaccharide-induced acute lung injury in mice. Journal of Surgical Research. 185(1). 364–372. 38 indexed citations
11.
Soromou, Lanan Wassy, Lanxiang Jiang, Miaomiao Wei, et al.. (2013). Protection of mice against lipopolysaccharide-induced endotoxic shock by pinocembrin is correlated with regulation of cytokine secretion. Journal of Immunotoxicology. 11(1). 56–61. 27 indexed citations
12.
Huo, Meixia, Lanxiang Jiang, Xuming Deng, et al.. (2013). Suppression of LPS-induced inflammatory responses by gossypol in RAW 264.7 cells and mouse models. International Immunopharmacology. 15(2). 442–449. 37 indexed citations
13.
Soromou, Lanan Wassy, Xiao Chu, Lanxiang Jiang, et al.. (2012). In vitro and in vivo protection provided by pinocembrin against lipopolysaccharide-induced inflammatory responses. International Immunopharmacology. 14(1). 66–74. 106 indexed citations
14.
Zhong, Weiting, Gefu Chi, Lanxiang Jiang, et al.. (2012). p-Cymene Modulates In Vitro and In Vivo Cytokine Production by Inhibiting MAPK and NF-κB Activation. Inflammation. 36(3). 529–537. 50 indexed citations
15.
Chu, Xiao, Xinxin Ci, Jiakang He, et al.. (2012). Effects of a Natural Prolyl Oligopeptidase Inhibitor, Rosmarinic Acid, on Lipopolysaccharide-Induced Acute Lung Injury in Mice. Molecules. 17(3). 3586–3598. 102 indexed citations
16.
Guo, Weixiao, Jingjing Sun, Lanxiang Jiang, et al.. (2012). Imperatorin Attenuates LPS-Induced Inflammation by Suppressing NF-κB and MAPKs Activation in RAW 264.7 Macrophages. Inflammation. 35(6). 1764–1772. 71 indexed citations
17.
Yang, Xiaofeng, Miaomiao Wei, Xianxing Xie, et al.. (2012). Geniposide, an Iridoid Glucoside Derived fromGardenia jasminoides, Protects against Lipopolysaccharide-Induced Acute Lung Injury in Mice. Planta Medica. 78(6). 557–564. 51 indexed citations
18.
Soromou, Lanan Wassy, Na Chen, Lanxiang Jiang, et al.. (2012). Astragalin attenuates lipopolysaccharide-induced inflammatory responses by down-regulating NF-κB signaling pathway. Biochemical and Biophysical Research Communications. 419(2). 256–261. 102 indexed citations
19.
Wei, Miaomiao, Xiao Chu, Lanxiang Jiang, et al.. (2012). Protocatechuic Acid Attenuates Lipolysaccharide-Induced Acute Lung Injury. Inflammation. 35(3). 1169–1178. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026